We found that ZD6126 can induce changes in the tumour periphery, as shown by the significant increase in cell proliferation associated to the viable tumour tissue (evaluated as the number of mitoses and Ki-67-positive cells) 24 h after its administration. Here, MKI67 is linked to neoplasm.